Advances in biomaterials and regenerative medicine for primary ovarian insufficiency therapy
Primary ovarian insufficiency (POI) is an ovarian dysfunction that affects more than 1 % of women and is characterized by hormone imbalances that afflict women before the age of 40. The typical perimenopausal symptoms result from abnormal levels of sex hormones, especially estrogen. The most prevale...
Main Authors: | Sichen Zhang, Dashuai Zhu, Xuan Mei, Zhenhua Li, Junlang Li, Mengjie Xie, Halle Jiang Williams Lutz, Shaowei Wang, Ke Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2021-07-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X20303339 |
Similar Items
-
Genetic etiology of primary premature ovarian insufficiency
by: Maja Franić-Ivanišević, et al.
Published: (2016-01-01) -
Role of microRNAs in premature ovarian insufficiency
by: Ying Guo, et al.
Published: (2017-05-01) -
Knockdown of the premature ovarian insufficiency candidate gene NUP107 in ovarian granulosa cells affects cell functions, including receptor expression and estrogen synthesis
by: Xiao-Cheng Liu, et al.
Published: (2019-01-01) -
Premature Ovarian Insufficiency - diagnostic and therapeutic challenges
by: Izabela Hawranik, et al.
Published: (2023-03-01) -
Loss of Calponin 2 causes premature ovarian insufficiency in mice
by: Tzu-Bou Hsieh, et al.
Published: (2024-02-01)